2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Burns | D002056 | 34 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Jain S et al. | Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles. | 2018 | AAPS PharmSciTech | pmid:28785860 |
| Liu J et al. | Quantitative ratiometric phosphorescence hypoxia-sensing nanoprobes based on quantum dots/Ir(III) glycerol monoolein cubic-phase nanoparticles. | 2017 | Biosens Bioelectron | pmid:28667838 |
| Esposito E et al. | Lipid nanoparticles for administration of poorly water soluble neuroactive drugs. | 2017 | Biomed Microdevices | pmid:28526975 |
| Ng WY et al. | Monoolein-alginate beads as a platform to promote adenosine cutaneous localization and wound healing. | 2017 | Int. J. Biol. Macromol. | pmid:28456646 |
| Takahashi H and Jojiki K | Water isotope effect on the lipidic cubic phase: Heavy water-Induced interfacial area reduction of monoolein-Water system. | 2017 | Chem. Phys. Lipids | pmid:28888939 |
| Ahirrao M and Shrotriya S | In vitro and in vivo evaluation of cubosomal in situ nasal gel containing resveratrol for brain targeting. | 2017 | Drug Dev Ind Pharm | pmid:28574732 |
| Cortesi R et al. | Monoolein aqueous dispersions as a delivery system for quercetin. | 2017 | Biomed Microdevices | pmid:28484916 |
| Esposito E et al. | Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.). | 2017 | Mater Sci Eng C Mater Biol Appl | pmid:27987758 |
| Ali MA et al. | Enhancing the Solubility and Oral Bioavailability of Poorly Water-Soluble Drugs Using Monoolein Cubosomes. | 2017 | Chem. Pharm. Bull. | pmid:28049915 |
| Szlezak M et al. | Monoolein Cubic Phase Gels and Cubosomes Doped with Magnetic Nanoparticles-Hybrid Materials for Controlled Drug Release. | 2017 | ACS Appl Mater Interfaces | pmid:28029248 |